Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In
  • Log Out

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
  • Log Out
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterCorrespondence

Specificity of Systemic Sclerosis Classification Criteria

MURRAY BARON, JANET E. POPE, FRANK VAN DEN HOOGEN, DINESH KHANNA, JAAP FRANSEN, SINDHU R. JOHNSON and MARCO MATUCCI-CERINIC
The Journal of Rheumatology December 2015, 42 (12) 2512; DOI: https://doi.org/10.3899/jrheum.150694
MURRAY BARON
Jewish General Hospital and McGill University, Montreal, Quebec;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mbaron@rhu.jgh.mcgill.ca
JANET E. POPE
St. Joseph’s Health Care London and University of Western Ontario, London, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANK VAN DEN HOOGEN
St. Maartenskliniek and Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DINESH KHANNA
University of Michigan, Ann Arbor, Michigan, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JAAP FRANSEN
Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SINDHU R. JOHNSON
Toronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARCO MATUCCI-CERINIC
University of Florence, Florence, Italy.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

As the steering committee of the American College of Rheumatology/European League Against Rheumatism project that developed the 2013 criteria for the classification of systemic sclerosis (SSc)1,2, we read with interest the publication of Hoffmann-Vold, et al3. Using data from the Norwegian Systemic Connective Tissue Disease and Vasculitis Registry, Hoffmann-Vold, et al’s report clearly supported the new criteria as having excellent sensitivity (96%) for SSc. The study was unique in that the authors had access to a large database of subjects with mixed connective tissue disease (MCTD) that was used to calculate specificity of the criteria for that particular illness. They reported a specificity of 90% for the new criteria.

We would like to make several points about their observations. The SSc classification criteria steering committee and the expert consultants involved in creating the new criteria agreed that the criteria could allow for classification of patients with another rheumatic disease as also having SSc1,2. It is well known that several rheumatic diseases may occasionally overlap with each other and the criteria were designed to recognize that fact. When applying the criteria to a patient to be used in an SSc study, it is up to the discretion of the researcher to decide whether patients with overlap features, or who may also meet criteria for other rheumatic diseases, should be included in the study.

MCTD itself is still a somewhat controversial entity4,5,6,7,8. Is MCTD a single discrete entity or does it represent a true overlap of several distinct diseases? If a patient labeled as having MCTD meets criteria for SSc, that patient may indeed have the illness we commonly call SSc, but may also have other concomitant conditions. So in that sense, the classification of that patient as having SSc is not an error or a false-positive result.

A second point is that specificity is clearly related to the population used as the comparator. And the predictive value of the criteria is related to the prevalence of the comparator diseases in the particular population from which the study subjects will be chosen. So realistically, if a center with expertise and interest in SSc were enrolling SSc subjects in a study, the prevalence of MCTD, even if it were a distinct disease, would likely be very low in the population from which the subjects were being chosen. Thus, the likelihood that a subject who meets SSc criteria actually has SSc is still very high. If you were to imagine a population of patients in which SSc and MCTD had equal prevalence, if all cases that met criteria were enrolled in an SSc study, only 9.4% of the subjects would have MCTD. And because equal prevalence of these 2 diseases is very unlikely, that would seem to be a maximum misclassification rate.

The last point is that even if MCTD is a discrete illness, a specificity for such a close mimicker of SSc of 90% could indeed be considered excellent. This is certainly in the same range or better than figures for the specificity of other rheumatic disease criteria9,10,11,12,13,14.

Finally, we are very grateful for this report of Hoffmann-Vold, et al because it confirms both the very high sensitivity of the SSc criteria and the very acceptable real-world specificity.

REFERENCES

  1. 1.↵
    1. van den Hoogen F,
    2. Khanna D,
    3. Fransen J,
    4. Johnson SR,
    5. Baron M,
    6. Tyndall A,
    7. et al.
    2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2013;72:1747–55.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. van den Hoogen F,
    2. Khanna D,
    3. Fransen J,
    4. Johnson SR,
    5. Baron M,
    6. Tyndall A,
    7. et al.
    2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2013;65:2737–47.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Hoffmann-Vold AM,
    2. Gunnarsson R,
    3. Garen T,
    4. Midtvedt Ø,
    5. Molberg Ø
    . Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease. J Rheumatol 2015;42:60–3.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Tani C,
    2. Carli L,
    3. Vagnani S,
    4. Talarico R,
    5. Baldini C,
    6. Mosca M,
    7. et al.
    The diagnosis and classification of mixed connective tissue disease. J Autoimmun 2014;48–49:46–9.
  5. 5.↵
    1. Alarcón-Segovia D
    . Mixed connective tissue disease: some statements. Clin Rheumatol 1982;1:81–3.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Swanton J,
    2. Isenberg D
    . Mixed connective tissue disease: still crazy after all these years. Rheum Dis Clin North Am 2005;31:421–36.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Venables PJ
    . Undifferentiated connective tissue diseases: mixed or muddled? Lupus 1998;7:73–4.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Cappelli S,
    2. Bellando Randone S,
    3. Martinović D,
    4. Tamas MM,
    5. Pasalić K,
    6. Allanore Y,
    7. et al.
    “To be or not to be,” ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum 2012;41:589–98.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Ighe A,
    2. Dahlström Ö,
    3. Skogh T,
    4. Sjöwall C
    . Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register. Arthritis Res Ther 2015;17:3.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Fonseca AR,
    2. Gaspar-Elsas MI,
    3. Land MG,
    4. de Oliveira SK
    . Comparison between three systems of classification criteria in juvenile systemic lupus erythematous. Rheumatology 2015;54:241–7.
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Sag E,
    2. Tartaglione A,
    3. Batu ED,
    4. Ravelli A,
    5. Khalil SM,
    6. Marks SD,
    7. et al.
    Performance of the new SLICC classification criteria in childhood systemic lupus erythematosus: a multicentre study. Clin Exp Rheumatol 2014;32:440–4.
    OpenUrlPubMed
  12. 12.↵
    1. Cornec D,
    2. Jousse-Joulin S,
    3. Marhadour T,
    4. Pers JO,
    5. Boisramé-Gastrin S,
    6. Renaudineau Y,
    7. et al.
    Salivary gland ultrasonography improves the diagnostic performance of the 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome. Rheumatology 2014;53:1604–7.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Hernández-Molina G,
    2. Avila-Casado C,
    3. Nuñez-Alvarez C,
    4. Cárdenas-Velázquez F,
    5. Hernández-Hernández C,
    6. Luisa Calderillo M,
    7. et al.
    Utility of the American-European Consensus Group and American College of Rheumatology Classification Criteria for Sjögren’s syndrome in patients with systemic autoimmune diseases in the clinical setting. Rheumatology 2015;54:441–8.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Le Loët X,
    2. Nicolau J,
    3. Boumier P,
    4. Daragon A,
    5. Mejjad O,
    6. Pouplin S,
    7. et al.
    Validation of the 2010-ACR/EULAR -classification criteria using newly EULAR-defined erosion for rheumatoid arthritis on the very early arthritis community-based (VErA) cohort. Joint Bone Spine 2015;82:38–41.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 42, Issue 12
1 Dec 2015
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Specificity of Systemic Sclerosis Classification Criteria
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Specificity of Systemic Sclerosis Classification Criteria
MURRAY BARON, JANET E. POPE, FRANK VAN DEN HOOGEN, DINESH KHANNA, JAAP FRANSEN, SINDHU R. JOHNSON, MARCO MATUCCI-CERINIC
The Journal of Rheumatology Dec 2015, 42 (12) 2512; DOI: 10.3899/jrheum.150694

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Specificity of Systemic Sclerosis Classification Criteria
MURRAY BARON, JANET E. POPE, FRANK VAN DEN HOOGEN, DINESH KHANNA, JAAP FRANSEN, SINDHU R. JOHNSON, MARCO MATUCCI-CERINIC
The Journal of Rheumatology Dec 2015, 42 (12) 2512; DOI: 10.3899/jrheum.150694
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Drs. Schneeberger and Citera reply
  • Dr. Kitajima et al reply
  • Dr. Putman et al reply
Show more Correspondence

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire